Great interview, thanks Bpharma. After all this time with all the associated hiccups and hold ups I must admit I am still holding on and still believe this company has a massive future.Hoping for the day when they can actually sell a therapy commercially but more significantly sell a therapy that answers a huge unmet need.Just the simple idea that an infection caused by many possible different bacteria might be treated with this single compound rather than having to cross match for a specific anti biotic seems life saving.
Good luck to all holders, hopefully current deals can get this over the line.
[INTERVIEW] Recce gearing up for Indonesian trials, page-15
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.3¢ |
Change
0.013(2.66%) |
Mkt cap ! $111.1M | |||
| Open | High | Low | Value | Volume |
| 47.5¢ | 48.5¢ | 47.5¢ | $70.05K | 145.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 34875 | 2 |
View Market Depth
| Last trade - 12.04pm 23/08/2024 (20 minute delay) ? |
| RCE (ASX) Chart |